Skip to Content

Advanced Calcium Hydroxyapatite (CaHA) Injectable Implant

Designed and Manufactured in the USA | ISO 13485:2016 Certified

PRODUCT PROFILE


CAHA SCULPT™ is a high-viscosity, non-pyrogenic, semi-solid cohesive implant. It is engineered for practitioners who require superior structural lifting capacity combined with long-term dermal revitalization.



Learn more

TECHNICAL DATA SUMMARY

  • Composition: 30% Calcium Hydroxyapatite (CaHA) microspheres; 70% Aqueous Gel Carrier.
  • Microsphere Precision: Smooth, spherical particles (25–45 μm) designed to optimize biocompatibility and prevent distal migration [1].
  • Rheology: High G-Prime (viscoelasticity) provides maximum projection and resistance to dynamic facial forces.
  • Non-Hydrophilic: Formulated to not attract water, ensuring immediate, predictable correction without post-procedural edema [2]. 


CLINICAL APPLICATIONS: FACE & HANDS

  • Facial Architecture: Targeted for the deep dermal and subdermal correction of volume loss and the definition of the jawline, chin, and mid-face.
  • Hand Restoration: Provides a smooth, uniform volume replacement on the dorsum of the hands, effectively masking tendons and veins [3].
  • Biostimulatory Versatility: In its hyper-diluted form (1:1+), the product functions as a skin-quality architect, stimulating the production of Type I Collagen and Elastin to improve skin laxity [4].

STRATEGIC PARTNERSHIP & WHITE LABELING

  • Advasaf provides a streamlined path for global partners to launch premium USA-made injectables.
  • Quality Systems: Manufactured in FDA-registered facilities under ISO 13485:2016 standards.
  • Custom Branding: Available for white-labeling and localized branding to fit regional market identities.


REGULATORY NOTICE: CAHA SCULPT™ is currently in the developmental phase and is not yet commercially available. Technical claims are based on established scientific benchmarks for Calcium Hydroxyapatite technology. 

TECHNICAL SOURCES & REFERENCES

  1. BOC Sciences (2024). Biocompatibility and Safety of Synthetic CaHA Microspheres.
  2. American Academy of Ophthalmology (EyeNet). Predictability of Non-Hydrophilic Dermal Fillers.
  3. FDA P050052. Clinical Data on CaHA for Hand Augmentation.

Goldie, K., et al. (2018).Global Consensus Guidelines for the Injection of Diluted and Hyperdiluted CaHA

Learn more